| Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. The Company's products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. It manufactures products in the United States, Puerto Rico and in eight foreign countries. On October 12, 2010, the Company acquired ZymoGenetics, Inc. (ZymoGenetics). In September 2011, the Company acquired Amira Pharmaceuticals, Inc. |
